Abbott

YTD

ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

CEO

Robert B. Ford

CEORobert B. Ford

Employees

115,000

Employees115,000

Headquarters

Abbott Park, Illinois

HeadquartersAbbott Park, Illinois

Founded

1888

Founded1888

Employees

115,000

Employees115,000

ABT Key Statistics

Market cap

190.43B

Market cap190.43B

Price-Earnings ratio

41.94

Price-Earnings ratio41.94

Dividend yield

2.22%

Dividend yield2.22%

Average volume

8.50M

Average volume8.50M

High today

$113.00

High today$113.00

Low today

$109.81

Low today$109.81

Open price

$111.19

Open price$111.19

Volume

8.24M

Volume8.24M

52 Week high

$132.03

52 Week high$132.03

52 Week low

$81.97

52 Week low$81.97

Stock Snapshot

With a market cap of 190.43B, Abbott(ABT) trades at $109.92. The stock has a price-to-earnings ratio of 41.94 and currently yields dividends of 2.22%.

On 2026-11-06, Abbott(ABT) stock moved within a range of $109.81 to $113.00. With shares now at $109.92, the stock is trading +0.1% above its intraday low and -2.7% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 8.24M, versus its average volume of 8.5M.

The stock's 52-week range extends from a low of $81.97 to a high of $132.03.

ABT News

MarketWatch 4h

Abbott Laboratories stock underperforms Friday when compared to competitors - MarketWatch

...

Simply Wall St 2d

Abbott Laboratories Reported Strong One Year Amulet 360 Trial Results

Abbott Laboratories (NYSE:ABT) reported strong one year VERITAS trial outcomes for its investigational Amulet 360 Left Atrial Appendage Occluder in non valvular...

Benzinga 4d

Abbott Touts Favorable Outcomes In Cardiovascular Device Trials

Abbott Laboratories (NYSE:ABT) reported positive clinical trial results for two investigational cardiovascular devices at the Transcatheter Cardiovascular Thera...

Analyst ratings

74%

of 31 ratings

Buy

74.2%

Hold

25.8%

Sell

More ABT News

Simply Wall St 5d

Abbott Laboratories Posts Positive SonicForce Trial Data, Is The Stock A Bargain?

Advertisement How the SonicForce trial update frames Abbott Laboratories stock Abbott Laboratories (ABT) just reported positive month results from its TECTONI...

Simply Wall St 6d

Nutrition Spin Off Might Change The Case For Investing In Abbott Stock

Abbott Laboratories has outlined a plan to separate its Nutrition business into a standalone public company and, in parallel, reported multiple medical device a...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.